Laboratory assessment of the status of Her-2/neu protein and oncogene in breast cancer specimens: comparison of immunohistochemistry assay with fluorescence in situ hybridisation assays
S Wang(The University of Texas Southwestern Medical Center), Raheela Ashfaq(Children's Medical Center)
Cited by 182
Related Papers
Assessment of HER-2/neu Status in Breast Cancer
|American Journal of Clinical Pathology|2001|143